Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 8, 2001

View Archived Issues

Licensing opportunity from NIH: virus-like particles as unlinked adjuvants

Topically applied CDK2 inhibitor prevents chemotherapy-induced hair loss

Role of PPARs and their ligands in atherogenesis incites a flurry of research

Abgenix plans to move ABX-IL-8 into phase IIb clinical trials for psoriasis

Sepracor pharmaceutical products portfolio update

Lexicon Genetics and Abgenix establish drug target validation collaboration

Oxford BioMedica initiates phase I/II clinical trial of TroVax as treatment of colorectal cancer

Phase IIb study of TP-10 in infants undergoing high-risk cardiac surgery now under way

Anti-EGF MAb produces clinical, biochemical improvement in patient with Menetrier's disease

Elan prepares launch of Myocet in Europe

Vertex commences phase II trial of VX-745 for rheumatoid arthritis

Positive final results emerge from INS-1 trial for type 2 diabetes

Antiinflammatory and antiemetic effects of YM-976 evaluated in animal studies

Macrolide antimicrobial agents related to erythromycin prepared at Abbott

Selective inhibitors of cathepsin S designed jointly by Medivir and Peptimmune

Patent issued to Hokuriku covering new antibacterial series

CeNeS licenses North American rights for Moraxen to Amarin; additional phase III study planned

Sumitomo presents new ECE inhibitors and their potential uses

Naturally produced compounds with antiplatelet and other properties discovered by Teijin

New series of sphingomyelinase inhibitors described by Ono researchers

Phase II head and neck cancer trial of Multikine cleared in Mexico

Antiinflammatory compounds from Bayer act as PDE4 inhibitors

Marketing agreement with Bioglan for Solaraze expanded by SkyePharma

Phase II IDEC-131 study begins in patients with ITP

Generex and Elan to form joint venture

Amarillo Biosciences reports completion of IFN-alpha phase III trial in Sjogren's syndrome

University of Pittsburgh awarded NHLBI grant for cardiovascular gene therapy program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...